- Investigator
- Roberto J Firpi-Morell
- Status
- Accepting Candidates
About me
I am a professor of medicine in the University of Florida Division of Gastroenterology, Hepatology & Nutrition, where I also oversee a multidisciplinary team as the director of hepatology and medical director of Liver Transplant and Program, and director of the Transplant Hepatology Fellowship for the section of hepatobiliary diseases and liver transplantation.
I received my medical degree in 1994 from the University of Puerto Rico School of Medicine, where I subsequently completed my internal medicine internship and residency. During my residency, I served as chief resident. Thereafter, I relocated to the U.S. and completed my gastroenterology fellowship here at UF under an NIH T32 training grant. I completed an additional fellowship in hepatology and liver transplant at Cedars-Sinai Medical Center/David Geffen School of Medicine at the University of California, Los Angeles (UCLA), where I received the AASLD Advanced Hepatology Fellowship Award in 2001. My area of clinical expertise is hepatology with an emphasis on the management of liver transplantation, viral hepatitis and immunosuppression after liver transplantation.
I have strong clinical and translational research interests, with more than five active clinical trials and multiple translational research initiatives underway. I have extensive interest in chronic hepatitis C infection and liver transplantation, publishing multiple papers related to hepatitis C and liver transplant and becoming a leader in the area. I serve as a reviewer for several journals, including the Journal of Liver Transplantation, American Journal of Gastroenterology, American Journal of Transplantation, Journal of Hepatology and Journal of Transplantation. I present my research annually at national meetings such as DDW, AASLD and the European International Meetings (EASL).
I also enjoy traveling to national and international universities as a visiting professor, including University of North Carolina, University of Puerto Rico, Oregon Health & Science University, Saint Luc Hospital in Montreal, Canada, Toronto General Hospital, University of Alberta Hospital and others.
My locations
Active clinical trials
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease…
- Investigator
- Roberto J Firpi-Morell
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a research registry of patients with NAFL or NASH within…
- Investigator
- Roberto J Firpi-Morell
- Status
- Accepting Candidates
- Ages
- 2 Years - N/A
- Sexes
- All
My research
Top areas of exploration
- Liver Transplantation , 20 publications
- Hepatitis C , 17 publications
- Recurrence , 13 publications
- Liver Cirrhosis , 13 publications
Research activity
Search our accepted insurances list
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.